Bildkälla: Stockfoto

Egetis Therapeutics: Strengthening the Aladote Patent Portfolio - Redeye

Redeye is encouraged by the news Egetis announced this morning. The company has been issued a Notice of Intent to Grant for a new patent for Aladote.

Redeye is encouraged by the news Egetis announced this morning. The company has been issued a Notice of Intent to Grant for a new patent for Aladote.
Börsvärldens nyhetsbrev
ANNONSER